Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Freedom 250 banner logo Join HHS in Celebrating Freedom 250
    • About HHS

      HHS is a U.S. executive department that touches the lives of nearly all Americans by protecting your rights, research, food safety, health care, aging, and much more.

    • Explore About HHS
    • About the Department
      • Leadership
      • HHS Divisions
      • Organizational Chart
      • Priorities
      • Budget in Brief
      • Contact Us
    • Press Room
      • Press Releases
      • Request for Comment
      • Request for Interview
      • Connect on Social Media
      • HHS Live
      • Podcasts
    • Careers
      • Working at HHS
      • Opportunities for Attorneys
      • Join the Health Workforce
      • I am HHS
      • New Employee Orientation
      • Transportation Services
    • Standards and Compliance
      • Gold Standard Science
      • Accessibility
      • Plain Writing
      • Digital Communications Standards
      • Records Management
    • Accountability and Transparency
      • Freedom of Information Act (FOIA)
      • Open Government
      • No Fear Act
      • Privacy at HHS
    • NUTRITION IN AMERICA

      HHS is advancing the Make America Healthy Again agenda by putting nutrition at the center of health. President Trump and Secretary Kennedy flipped the food pyramid to encourage Americans to Eat Real Food.

    • Explore Nutrition in America
    • Advancing Nutrition Education
    • Make Hospital Food Healthy Again
    • Eat Real Food
    • The Real Food Show
  • MAHA
    • Programs & Services

      HHS is responsible for public health, health care, and human/social services for the United States of America. This includes administering over 100 programs and services.

    • Explore Programs & Services
    • Health Care
      • Find a Health Center
      • Find an Indian Health Service Facility
      • Find Support for Mental Health, Drugs, or Alcohol
      • Find a Cancer Center
      • Dental Care Options
      • Telehealth
    • Health Insurance
      • Medicare – 65+ or With Disability
      • Medicaid - Low-Income, With Disability, or Pregnant
      • Children’s Health Insurance Programs (CHIP)
      • Find Health Insurance Coverage
      • Insurance Help for Mental Health and Substance Use
      • No Surprise Medicals Bills
    • Social Services
      • Programs for Children and Families
      • Programs for People with Disabilities
      • Programs for Older Adults
      • Resources for Caregivers
    • Public Health and Prevention
      • Emergency Preparedness and Response
      • Healthy Lifestyle
      • Mental Health and Substance Use
      • Food Safety and Nutrition
      • Drug and Product Safety
    • Health Research and Information
      • National Library of Medicine
      • Surgeon General Reports
      • Health Data
      • National Center for Health Statistics
      • Medline Plus
      • Clinical Research Studies
      • Volunteering to Participate in Research
    • Laws & Regulations

      HHS protects and helps you understand the laws and regulations, also known as "rules," that govern the nation. You also have the power to voice your opinion on these laws and regulations.

    • Explore Laws & Regulations
    • Regulatory Information
      • What is a Rule?
      • Find Rules by Division
      • Comment on Open Rules
      • Suggest Deregulatory Actions
      • Understand Key Federal Laws
    • Civil Rights
      • Your Civil Rights
      • Civil Rights Laws Enforced by HHS
      • Health Information Privacy
      • Substance Use Disorder Patient Confidentiality
      • Conscience and Religious Freedom
    • Laws and Regulations by Topic
      • HIPAA Privacy Rule
      • Health Insurance Protections
      • Health IT Legislation
      • Food and Drug Safety
      • Public Health Emergencies
    • Human Research Protections
      • The Belmont Report
      • Regulations, Policy, and Guidance
      • Human Subjects Regulations (45 CFR 46)
      • Register IRBs and Obtain FWAs
      • Trainings, Tutorials, and Workshops
      • International Research
    • Complaints and Appeals
      • File a Medicare Complaint
      • File a HIPAA Complaint
      • File a Civil Rights Complaint
      • Appeal an Insurance Company Decision
      • Report Fraud, Waste, and Abuse to OIG
      • Report a Problem to the FDA
      • Report a Tip on the Chemical and Surgical Mutilation of Children
    • Grants & Contracts

      HHS gives the most money in grants of any federal agency in the U.S. Find out about our grants and how your organization can apply for them. We also provide information on how you can work with us and our support of small businesses.

    • Explore Grants & Contracts
    • Grants
      • Get Ready for Grants Management
      • Grant Policies and Regulations
      • Research Grants and Funding from NIH
      • Search Grants.gov
      • Avoid Grant Scams
      • Contact HHS Grant Officials
    • Contracts
      • Get Ready to Do Business with HHS
      • Programs for Businesses
      • Contract Policies and Regulations
      • Search Opportunities on SAM.gov
      • Contact HHS Contracting Managers
    • Small Business
      • Contract Opportunities
      • Small Business Programs
      • Small Business Resources
      • Contact Small Business Staff
    • Radical Transparency

      HHS protects and helps you understand the laws and regulations, also known as "rules," that govern the nation. You also have the power to voice your opinion on these laws and regulations.

    • Explore Radical Transparency
    • CDC’s ACIP Conflicts of Interest
    • Ending Anti-Semitism on College Campuses
    • Ending Wasteful Spending
    • Keeping Food Ingredients Safe
    • Chemical Contaminants Transparency Tool
Breadcrumb
  1. Home
  2. Press Room
  3. HHS Announces ARPA-H Awards to Advance Ibogaine Development for PTSD & New $20 Million Funding Opportunity to Advance Rapid-acting Psychotropics
  • Press Room
  • HHS Live
  • Podcasts
    • The Secretary Kennedy Podcast
  • Social Media
FOR IMMEDIATE RELEASE
November 12, 2026
Contact: HHS Press Office
202-690-6343
Submit a Request for Comment

HHS Announces ARPA-H Awards to Advance Ibogaine Development for PTSD & New $20 Million Funding Opportunity to Advance Rapid-acting Psychotropics

WASHINGTON—NOVEMBER 12, 2026—The U.S. Department of Health and Human Services (HHS) today made several announcements to advance the development of mental health treatments for veterans and civilians. First, HHS Secretary Robert F. Kennedy, Jr., announced investments up to $4.9 million through the Advanced Research Projects Agency for Health (ARPA-H) to advance the development of ibogaine as a potential treatment for post-traumatic stress disorder (PTSD) and other serious mental illnesses, including in Veterans.

Second, the National Institute of Mental Health (NIMH) published a $20 million Notice of Funding Opportunity (NOFO) to support the development of a research network to study rapid-acting psychotropic interventional drugs (RAPIDs), such as ketamine, esketamine, psilocybin, and other emerging treatments for serious mental illnesses. Award recipients will be announced the summer of 2027.

Secretary Kennedy was joined by leaders from the Department of Veterans Affairs to announce the investment the day after Veterans Day. The ARPA-H efforts support preparation of Investigational New Drug Applications (INDs) to enable future clinical trials in the United States, secure clinical-grade ibogaine, and develop processes for sustainable domestic manufacturing.

“Veterans kept their promise to this country. We must keep ours,” said Secretary Kennedy. “Veterans have told us ibogaine changed their lives. Their experiences demand serious scientific investigation. We will pursue the evidence, confront the risks and put affordability at the center of this work.”

The research teams selected by ARPA-H are led by the Mark Cuban Cost Plus Drug Company, PBC, will establish the regulatory, clinical, chemical, and engineering foundation for a domestically manufactured, single-molecule ibogaine hydrochloride product for potential PTSD treatment. Separately, Beond, Inc., will deliver high-fidelity clinical data to evaluate the safety, dosing, efficacy, and durability of ibogaine to facilitate further understanding and development. If successful, the resulting evidence from these efforts may support carefully controlled development in more clinically complex and higher-risk indications. All awardees will open-source data from their research findings to accelerate further research on ibogaine.

The agency’s initial commitment is up to $4.9 million over five years with additional awards expected that will include a focus on ibogaine as a potential treatment for substance use disorders (SUD). Performer awards vary in funding amount per awardee and are contingent upon each team meeting aggressive and accelerated research milestones. These awards fund the regulatory and manufacturing groundwork for future trials. It does not fund treatment of patients or human-subject research, and it does not authorize clinical trials or establish FDA approval.

“Our U.S. Veterans and the millions of other Americans suffering from serious mental illness deserve the best possible care,” said Al Bugazia, M.D., Senior Advisor for Special Projects at ARPA-H, who is leading the effort. “Reports of successful ibogaine treatments are too promising to ignore. We owe it to our heroes and every person struggling to ask the bold questions and deliver results in years, not decades. As long as people continue to struggle, doing anything less is not an option.”

Future ARPA-H awards will evaluate ibogaine as a potential treatment for SUD, including opioid use disorder. Rather than betting on a single path, ARPA-H is pursuing multiple IND applications across more than one indication. This strategy is designed to increase the odds that at least one approach produces clear answers about whether ibogaine can be an effective, rapid-treatment option for Veterans and other Americans struggling with serious mental illness.

“Veterans deserve effective treatments and clear answers about the benefits and risks of those treatments,” said VA Secretary Doug Collins. “We look forward to working with HHS to explore the possibilities of ibogaine and prepare our clinicians to deliver new treatments if they earn FDA approval.”

Ibogaine carries serious safety risks, including potentially life-threatening heart rhythm problems. Its potential benefits require rigorous evaluation. Future clinical studies must address participant screening, cardiac monitoring and independent safety oversight, alongside the scientific questions needed to assess whether the treatment works.

HHS is also prioritizing affordability from the outset. If development succeeds and the medicine earns FDA approval, the goal is to make it available at the cost of production plus a fair margin.

HHS also committed to making research findings public, whether they show benefit, no benefit or harm, while protecting patient privacy.

The announcement advances President Trump’s April directive to accelerate research into promising psychedelic treatments. It also builds on the HHS–VA partnership to expand clinical research, share evidence and prepare the healthcare workforce to deliver future FDA-approved treatments.

“We owe veterans more than promises,” said Secretary Kennedy. “We owe them rigorous science, honest answers and a path to affordable care if the evidence supports it.”

Veterans in crisis, and anyone concerned about a veteran, can call 988 and press 1 to reach the Veterans Crisis Line.

###
Note: All HHS press releases, fact sheets and other news materials are available in our Press Room.
Like HHS on Facebook, follow HHS on X @HHSgov, @SecKennedy, and sign up for HHS Email Updates.
Last revised: November 12, 2026

Submit a request for comment

For media inquiries, please submit a request for comment.

Sign up to receive our press releases

Sign Up

Related Press Releases

  • HHS Awards $2 Million to Advance Chronic Disease Prevention in American Indian and Alaska Native Communities

    • November 20, 2026 Press Release
  • HHS Announces $2.25 Million for Phase 1 Winners of the Caregiver AI Prize Challenge: Smarter Tools, Stronger Care

    • November 18, 2026 Press Release
  • HHS Expands TOPx Prize Pool to $3.8 Million, Announces $3.7 Million in TOPx prizes for AI Tools Addressing Lyme Disease and Invisible Illnesses

    • November 9, 2026 Press Release
Content last reviewed November 12, 2026
Back to top
Secretary Robert F. Kennedy Jr.

Follow @SecKennedy

HHS icon

Follow @HHSGov

HHS Email updates

Receive email updates from HHS.

Subscribe

HHS Logo

HHS Headquarters

200 Independence Avenue, S.W.
Washington, D.C. 20201
Toll Free Call Center: 1-877-696-6775​

  • Contact HHS
  • Careers
  • HHS FAQs
  • Nondiscrimination Notice
  • Press Room
  • HHS Archive
  • Accessibility Statement
  • Privacy Policy
  • Budget/Performance
  • Inspector General
  • Web Site Disclaimers
  • EEO/No Fear Act
  • FOIA
  • The White House
  • USA.gov
  • Vulnerability Disclosure Policy